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Tissue-Specific Activities of C. elegans DAF-16
in the Regulation of Lifespan
tissues play an important role in establishing the ani-
mal’s rate of aging. First, the C. elegans genome con-
tains more than 35 insulin-like genes expressed in a
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variety of neurons and other tissues, and some of theseMission Bay Genentech Hall
have been implicated in lifespan regulation (Kawano et600 16th Street, Room S312D
al., 2000; Li et al., 2003; Murphy et al., 2003; Pierce etUniversity of California, San Francisco
al., 2001). In addition, in response to insulin-like ligands,San Francisco, California 94143
cells that express the DAF-2 receptor are thought to
produce (or stop producing) downstream signals or hor-
mones, because daf-2 acts cell non-autonomously toSummary
influence lifespan (Apfeld and Kenyon, 1998; Wolkow et
al., 2000). For example, removing daf-2 from either ofIn C. elegans, the transcription factor DAF-16 pro-
the two blastomeres of the two-cell embryo lengthensmotes longevity in response to reduced insulin/IGF-1
the lifespan of the entire animal (Apfeld and Kenyon,signaling or germline ablation. In this study, we have
1998).asked how different tissues interact to specify the life-
Recent studies suggest that the DAF-2 pathway mayspan of the animal. We find that several tissues act as
regulate multiple downstream signals. One potential sig-signaling centers. In particular, DAF-16 activity in the
nal is SCL-1, a member of the CRISP family of secretedintestine, which is also the animal’s adipose tissue,
proteins. scl-1 expression is upregulated in daf-2 mu-completely restores the longevity of daf-16() germ-
tants, and contributes to their longevity (Ookuma et al.,line-deficient animals, and increases the lifespans of
2003). The DAF-2 pathway also regulates several insulin-daf-16() insulin/IGF-1-pathway mutants substantially.
like genes. For example, expression of ins-7, which en-Our findings indicate that DAF-16 may control two
codes a putative DAF-2 agonist, is upregulated by DAF-2types of downstream signals: DAF-16 activity in signal-
pathway activity (Murphy et al., 2003). In addition, aing cells upregulates DAF-16 in specific responding
number of longevity genes encoding signaling proteins,tissues, possibly via regulation of insulin-like peptides,
as well as proteins that could be involved in synthesisand also evokes DAF-16-independent responses. We
of lipophilic hormones, are regulated in a daf-16-depen-suggest that this network of tissue interactions and
dent manner (Lee et al., 2003; McElwee et al., 2003;feedback regulation allows the tissues to equilibrate
Murakami and Johnson, 2001; Murphy et al., 2003).and fine-tune their expression of downstream genes,
DAF-2 (and by extension, DAF-16), has been thoughtwhich, in turn, coordinates their rates of aging within
to function primarily in the nervous system to influencethe animal.
lifespan. Mosaics lacking daf-2 in AB, a lineage produc-
ing mainly ectodermal cell types (neurons and epider-Introduction
mis) are quite long lived, as was one mosaic lacking
daf-2 in a small group of neurons (Apfeld and Kenyon,How signaling between tissues coordinates the physiol-
1998). In addition, expression of daf-2 using neural pro-ogy of an animal is a fundamental problem in endocrinol-
moters has been reported to shorten the lifespan ofogy. The aging of C. elegans is controlled by an endo-
daf-2 mutants to control levels (Wolkow et al., 2000). Itcrine system that also regulates the lifespans of flies
seemed possible that DAF-16 might function in a differ-and mammals (Tatar et al., 2003). Reduction-of-function
ent tissue to promote longevity in another situation: The
mutations affecting the insulin/IGF-1-like receptor DAF-2,
lifespan of C. elegans is increased by removing the
or components of a downstream PI 3-kinase/PDK/AKT
germline, and this lifespan extension, like that of DAF-2
pathway, double the animal’s lifespan (Kenyon et al., pathway mutants, requires DAF-16 activity (Hsin and
1993; Kimura et al., 1997; Larsen et al., 1995; Morris Kenyon, 1999). Curiously, whereas DAF-16 accumulates
et al., 1996; Paradis and Ruvkun, 1998). This lifespan in the nuclei of many cell types in daf-2 mutants, in
extension requires DAF-16, a member of the FOXO- germline-deficient animals DAF-16 accumulates primar-
family of transcription factors (Kenyon et al., 1993; Larsen ily in intestinal nuclei (Lin et al., 2001). This finding has
et al., 1995; Lin et al., 1997; Ogg et al., 1997). In the wild- suggested that DAF-16 might function primarily in the
type, the AKT-1 and AKT-2 proteins phosphorylate DAF- intestine to promote longevity in these animals.
16, inhibiting its nuclear localization (Henderson and In this study, we have investigated the tissue-specific-
Johnson, 2001; Lee et al., 2001; Lin et al., 2001). In DAF-2 ity of DAF-16 function. Surprisingly, we find that DAF-
pathway mutants, DAF-16 accumulates in the nuclei of 16 activity in neurons is sufficient to produce only a
many cell types, where it leads to changes in the expres- modest, 5%–20%, extension of lifespan in daf-16();
sion of a wide variety of metabolic, stress response, daf-2() animals. However, we find that DAF-16 activity
antimicrobial, and novel genes, and thereby extends in the intestine is sufficient to extend the lifespans of
lifespan (Lee et al., 2003; McElwee et al., 2003; Murphy these animals by 50%–60%, and can completely rescue
et al., 2003). the longevity of daf-16() germline-defective mutants.
Several findings suggest that interactions between We also find that DAF-16 activity in signaling cells elicits
two types of responses, one that requires DAF-16 activ-
ity in responding cells, and thus may involve feedback*Correspondence: ckenyon@biochem.ucsf.edu
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regulation of insulin production, and one that does not. become dauers even in the presence of food (Riddle
and Albert, 1997), and this requires daf-16 (Gottlieb andMoreover, different tissues differ in their ability to send
and respond to these signals. This intricate network Ruvkun, 1994; Larsen et al., 1995; Riddle et al., 1981;
Vowels and Thomas, 1992). The daf-2 mutation we used,of feedback regulation and cross-communication may
coordinate the expression of downstream longevity e1370, causes dauer formation at 25C. We found that
expression of DAF-16::GFP in neurons was sufficient togenes in different tissues, and thereby specify the rate
of aging of the animal as a whole. promote dauer formation in daf-16(mu86); daf-2(e1370)
mutants (Table 2). In contrast, muscle daf-16::gfp ex-
pression did not rescue dauer formation, and intestinalResults
daf-16::gfp had only a small effect (Table 2). Thus, we
concluded that neither muscle nor intestinal DAF-16 isdaf-16 Function in the DAF-2 Pathway:
necessary or sufficient for dauer formation, and thatTissue-Specific Expression
neuronal DAF-16 can be sufficient.To investigate whether daf-16 activity in any single tis-
We also attempted to express daf-16 in the epidermis.sue was sufficient to extend the lifespan of daf-2 mu-
However, using either of two epidermal promoters (seetants, we expressed a DAF-16::GFP fusion in a tissue-
Experimental Procedures), we were unable to generatespecific fashion. As a control, we expressed the fusion
transgenic lines expressing DAF-16::GFP at control orunder the control of the daf-16 promoter in daf-16();
even very low levels. Instead, the GFP-expressing ani-daf-2() animals, and found that it almost completely
mals invariably died as embryos or young larvae. Thisrescued their longevity to daf-16(); daf-2(e1370) levels
suggests that expression of daf-16 in the epidermis may(Figure 1A; Table 1). We then expressed daf-16::gfp spe-
be lethal unless accompanied by expression elsewhere.cifically in neurons, muscle or intestine by fusing it to
the unc-119, myo-1, or ges-1 promoters, respectively.
The fusions were expressed in the predicted tissue- daf-16 Function in the DAF-2 Pathway:
Genetic Mosaic Analysisspecific fashion during development and most of adult-
hood at levels comparable to or higher than those ob- A complementary way to investigate tissue specificity
is to remove gene function from a subset of lineages,served in the Pdaf-16::GFP::daf-16 control animals
(Supplemental Figures S1–S3, available online at http:// which generates genetic mosaics (Herman, 1984). C.
elegans has an invariant cell lineage (Sulston and Hor-www.cell.com/cgi/content/full/115/4/489/DC1).
Because DAF-16 had been predicted to function pri- vitz, 1977; Sulston et al., 1983). The fertilized egg divides
to produce the AB blastomere, which generates muchmarily in neurons, we were surprised to find that in each
of three independent lines, neuronal daf-16 expression of the ectoderm, including most of the epidermis and
all but a few neurons; and the P1 blastomere, whichonly increased lifespan 5%–20%, up to that of wild-type
(Figure 1B; Table 1). We wondered whether our neuronal produces the intestine, muscle, reproductive system,
and dorsal epidermis (see Figure 2A). In C. elegans,fusion might be toxic to the worm, thereby masking a
longevity function. To test this, we expressed neuronal genetic mosaics can be produced by the spontaneous
loss of an extrachromosomal array carrying the animal’sdaf-16 in daf-16(); daf-2() animals. These animals
lived as long as the daf-2() controls (Supplemental only wild-type gene copy as well as genes that function
as cell lineage markers (see Experimental Procedures).Figure S4A [available at above URL]; Table 1), arguing
against this possibility. We also created a series of trans- The markers we used allowed us to identify mosaics
lacking daf-16 in the entire AB lineage (AB-mosaics),genic lines in which neuronal daf-16::gfp was expressed
from very low to very high levels, and found that none the entire P1 lineage (P1-mosaics), or in either the EMS
or E lineages (we refer to these as E(MS)-mosaics; seeof these lines lived longer than wild-type (Supplemental
Figures S4B–S4D; Table 1). Finally, we confirmed that Experimental Procedures and Figure 2) of otherwise daf-
16(); daf-2() animals. In two independent experi-our neuronal daf-16 fusions were functional, because
they were able to induce a different daf-16-dependent ments, we found that both AB-mosaics and P1-mosaics
had extended lifespans (Figure 2B; Table 3). This impliesresponse, dauer formation (see below). Thus we con-
cluded that neuronal daf-16 activity is sufficient to ex- that daf-16 functions cell non-autonomously in both AB-
and P1-derived tissues to signal the daf-16() cells intend lifespan, but only modestly.
We found that expressing daf-16 specifically in mus- the animal to age more slowly. The lifespan extension
observed when DAF-16 was present only in the AB lin-cles produced no lifespan extension (Figure 1C; Table 1).
In contrast, expressing daf-16 in the intestine increased eage (P1-mosaics) was small, similar to that produced
by DAF-16 expression in neurons alone (Figures 1B andlifespan substantially, by 50%–60% (Figures 1D and 1E;
Table 1). Injecting a higher concentration of the intestinal 2B; Tables 1 and 3). This suggests that neurons may be
the main AB-derived tissue in which DAF-16 activitytransgene did not further extend the lifspans of these
animals (Figure 1E; Table 1). Therefore, we concluded can be sufficient to produce an extension in lifespan.
Conversely, AB-mosaics, which contained daf-16 in thethat DAF-16 function in the intestine is sufficient to in-
crease lifespan substantially, but that for full lifespan entire P1 lineage, had longer lifespans (Figure 2B; Table
3). Unexpectedly, the data suggested that nonintestinalextension, its function in one or more other tissues is
also required. as well as intestinal P1-derived cells contributed to this
longevity: E(MS)-mosaics (in which DAF-16 was pres-In addition to longevity, DAF-2 and DAF-16 also regu-
late dauer formation (Riddle and Albert, 1997). Dauer is ent in AB- and also some P1-derived cells) lived longer
than P1-mosaics (in which DAF-16 was present only inan alternative, growth-arrested, juvenile state induced
by food limitation and crowding (Golden and Riddle, AB) (Figure 2B; Table 3), and both of these mosaics
lacked DAF-16 in the intestine. These experiments also1982; Golden and Riddle, 1984). Strong daf-2 mutants
Tissue Specificity of DAF-16
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Figure 1. Effects of Tissue-Specific DAF-16 Activity on the Lifespans of daf-16(mu86); daf-2(e1370) Mutants
(A) DAF-16 driven by its own promoter can rescue the lifespan of the daf-16(mu86); daf-2(e1370) mutants to nearly daf-2(e1370) levels. (B)
Neuronal DAF-16 has a small effect and (C) muscle DAF-16 has no effect on daf-16(mu86); daf-2(e1370) lifespan. (D and E) Intestinal DAF-
16 can increase daf-16(mu86); daf-2(e1370) lifespan by 50%–60%.
The curves in this and subsequent figures represent the sum of animals examined in one or more experiments (see Table 1). Logrank (Mantel-
Cox) statistics confirmed the hypothesis that animals in combined experiments behaved similarly. Transgenic animals carried the rol-6 (pRF4)
coinjection marker in (A), (B), (C), and (E), and Podr-1::rfp in (D). Ex and Is represent transgenes carried as extrachromosomal or integrated
arrays. Transgenes are indicated by a Kenyon-lab allele number in each panel (the allele prefix mu is omitted). Transgenes (Ex) were injected
into daf-16(mu86); daf-2(e1370) animals at 50 ng/l, except muEx181 in (A), which was injected at 30 ng/l, and muEx227 in (E), which was
injected at 100 ng/l. Each muEx represents an independent line (in this and subsequent figures). The rol-6 coinjection marker alone had no
effect on daf-2(e1370) (p 0.23) or daf-16(mu86); daf-2(e1370) lifespan (p 0.25), and the Podr-1::rfp coinjection marker had no effect on daf-
16(mu86); daf-2(e1370) lifespan (p 0.15). In (D), daf-16; daf-2-S represents non-RFP-expressing siblings selected under the fluorescent
dissecting scope in parallel with transgenic animals. In (E), transgenic lines were crossed into daf-16(mu86); daf-2(e1370) animals carrying
the integrated sod-3::GFP transgene (muIs84).
demonstrated that the combined effects of DAF-16 ac- This suggests that daf-16 does not act exclusively in
neurons to regulate dauer formation, but in other tissuestivity in the nonintestinal tissues are sufficient to in-
crease lifespan substantially, since mosaics lacking as well.
DAF-16 specifically in the intestine (MS) had lifespans
that were only 17%–30% shorter than those of control RNAi Analysis of DAF-16 Neuronal Activity
Both our tissue-specific expression and mosaic experi-daf-16(); daf-2() animals.
We also tested for dauer formation at 25.5C (see ments indicated that daf-16 expression in neurons is
not sufficient to extend lifespan by more than aboutExperimental Procedures), and found that both AB- and
P1-mosaics were able to become dauers (Figure 2C). 20%. Because DAF-16 had been predicted to function
Cell
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Table 1. Adult Lifespans of Animals with Tissue-Specific daf-16 Expression
Conc. Mean No. died/ p value
injected lifespan total no. p value against
transgene SEM animals# against specified
Genotype (ng/l) (days) (no. trials) % control control group
Background Transgene/Line
daf-16(mu86); daf-2(e1370) none 16.1  0.2 420/741 (13)
Pdaf-16::gfp::daf-16/muEx176 50 36.9  1.2 93/256 (3) 129% 0.0001 0.0001†
muEx181 30 35.1  2.4 32/257 (3) 118% 0.0001 0.02†
Punc-119::gfp::daf-16/
muEx169 50 19.7  1.0 32/46 (1) 16.6% 0.009 0.45ø
muEx171 50 19.4  0.6 84/96 (1) 21.3% 0.0001 0.001ø
muEx184 50 17.8  1.1 22/32 (1) 5.3% 0.75 0.042ø
muEx213 1 15.6  0.5 56/80 (1) 4.8% 0.83 0.0002ø
muEx214 1 17.2  0.7 57/80 (1) 11.2% 0.009 0.64ø
muEx239 1 16.4  0.5 51/61 (1) 3.9% 0.14 0.0009ø
muEx144 30 15.6  0.5 75/92 (1) 0.6% 0.39 0.002ø
muEx145 30 15.9  0.7 52/79 (1) 1.3% 0.39 0.007ø
muEx284 100 18.1  1.0 45/70 (1) 12.2%ß 0.001ß 0.37ø
Pmyo-3::gfp::daf-16/muEx212 50 17.1  0.5 67/90 (1) 4.3% 0.47
muEx215 50 16.3  0.5 43/70 (1) 1.2% 0.65
muEx229 50 16.0  0.4 82/101 (1) 1.3% 0.56
daf-16(mu86); daf-2(e1370)‡ none 15.7  0.3 112/209 (3)
Pges-1::gfp::daf-16/muEx285¶ 50 26.8  1.1 40/85 (1) 77.5% 0.0001 0.0001†
muEx267¶ 50 23.7  0.8 53/126 (1) 47.2% 0.0001 0.0001†
muEx268¶ 50 24.1  0.7 82/147 (1) 50.6% 0.0001 0.0001†
daf-16(mu86); daf-2(e1370);
muIs84 none 14.9  0.3 109/223 (3)
Pges-1::gfp::daf-16/muEx211 50 24.4  0.7 95/166 (2) 64.1% 0.0001 0.0001†
muEx227 100 23.0  1.0 58/81 (1) 54.5% 0.0001 0.0001†
daf-2(e1370) none 43.5  0.5 659/858 (14)
Punc-119::gfp::daf-16/
muEx208 50 40.9  1.3 54/71 (1) 0.5% 0.84
muEx209 50 42.4  1.0 108/141 (1) 4.2% 0.64
muEx218 50 40.1  2.4 30/71 (1) 1.5% 0.86
daf-16(mu86); mes-1(bn7) sterile none 12.2  0.2 178/364 (4)
Pdaf-16::gfp::daf-16/muEx248¶ 50 23.1  0.9 62/117 (1) 62.7% 0.0001 0.53¥
Punc-119::gfp::daf-16/
muEx245¶ 50 15.1  0.5 69/117 (1) 13.5% 0.0044 0.59£
muEx246¶ 50 15.1  0.6 36/99 (1) 13.5% 0.0028 0.67£
Pmyo-3::gfp::daf-16/muEx232¶ 50 13.4  0.4 71/98 (1) 3.9% 0.45
muEx236¶ 50 12.2  0.6 46/92 (1) 5.4% 0.41
Pges-1::gfp::daf-16/muEx254¶ 50 23.3  0.9 97/197 (2) 77.9% 0.0001 0.44¥
Transgenes were coinjected with the rol-6 (pRF4) marker at 100 ng/l, except in lines with a superscripted symbol¶, in which transgenes were
coinjected with the Podr-1::rfp marker at 100 ng/l.
# Some animals were censored (see Experimental Procedures). The number of independent trials is in parentheses. The % difference between
mean lifespans of transgenic animals and those of their respective controls is indicated in the sixth column. Transgenic animals in each group
are compared to their respective non-transgenic controls (genotype indicated in the first column under “Background”). p values represent
the probability that the estimated survival function of the experimental group of animals is equal to that of the control group. p values are
determined using the logrank (Mantel-Cox) statistics. p values less than 0.05 are considered statistically significant, demonstrating that the
two survival functions are different. In the eighth column, p values are against a group specified by a superscripted symbol: †, daf-2(e1370);
ø, N2; ¥, mes-1(bn7) sterile; £, daf-16(mu86); mes-1(bn7) fertile controls, which live 23.5% longer than daf-16(mu86); mes-1(bn7) sterile animals
(p  0.0001).
In (1)-trial experiments the “% control” and p values are relative to the controls assayed in parallel with the experiments (except in , when
they are relative to a cumulative daf-16(mu86); daf-2(e1370) control). In (2)- or more trial experiments “% control” and p values are relative
to controls combined from 2 or more experiments. (We show cumulative statistics in this table and relevant figures because experimental
animals compared to their respective controls assayed at the same time, and to cumulative controls, behaved similarly.) ‡ Non-transgenic
siblings of transgenic animals that were selected under fluorescent dissecting scope.
primarily in neurons, we addressed this issue in a third tablished an in vivo assay for DAF-16 activity. The super-
oxide dismutase gene sod-3 is thought to be a directway as well. Previously we found that treating wild-
type animals with daf-2 RNAi doubled lifespan, and that target of DAF-16 (Furuyama et al., 2000; Honda and
Honda, 1999). Therefore we constructed strains con-treating daf-2() animals with daf-16 RNAi suppressed
their 2-fold lifespan extension to wild-type levels (Dillin taining a Psod-3::gfp transcriptional fusion (see Supple-
mental Experimental Procedures) and subjected themet al., 2002). This was unexpected, because neurons
are known to be refractory to RNAi (Fraser et al., 2000; to RNAi. In the absence of RNAi, this fusion was ex-
pressed in only a few cells in wild-type (Figure 3A); inKamath et al., 2000). To test directly whether these RNAi
treatments affected neuronal gene expression, we es- daf-2() mutants it was expressed in many more cells,
Tissue Specificity of DAF-16
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Figure 2. Lifespan and Dauer Formation of daf-16 Genetic Mosaics
(A) Tissues produced by the early blastomeres of C. elegans. (B) Survival curves for daf-16 genetic mosaics. Experiment #1, mosaic animals
were selected at 20C as L4 larvae; experiment #2, mosaic animals were selected as dauers or non-dauers at 25.5C, dauers were allowed
to exit dauer at 15C. In both experiments, lifespans were determined at 20C. daf-2() control: daf-16(mu86); daf-2(e1370) ncl-1(e1865);
muEx258, where muEx258 is an extrachromosomal array carrying a genomic DAF-16 clone, as well as markers used to identify mosaics (see
Experimental Procedures). daf-16(); daf-2() control: animals that have lost muEx258 in all tissues. (C) Relative frequencies of dauer and
L4 larvae among daf-16 genetic mosaics in experiment #2 (see Experimental Procedures). We examined 85 AB-mosaics, 38 P1-mosaics and
173 E(MS)-mosaics. In experiment #1, approximately 15% of AB-mosaics formed dauers, whereas P1-mosaics invariably developed into L4
larvae. These experiment #1 AB dauers took 2–6 days to recover and were asynchronous in reaching L4, suggesting that DAF-16 activity in
AB might be necessary for dauer exit.
including many neurons (Figure 3B). When we subjected downstream hormones to feedback regulate DAF-2 ac-
tivity. If DAF-16 controls an insulin-like peptide or an-wild-type worms to daf-2 RNAi, Psod-3::gfp was upregu-
lated in nonneuronal tissues, but we did not detect other hormone that signals through wild-type DAF-2 and
DAF-16, we would not have been able to detect it inupregulation in neurons (Figure 3A). Yet these animals
lived twice as long as normal (Figure 3, legend). When our tissue-specific expression or mosaic experiments
because the potential responding cells were daf-16();we subjected daf-2() mutants to daf-16 RNAi, Psod-3::
GFP was downregulated in most tissues, but we did not daf-2(). Therefore, we designed an experiment that
could detect such a signal by using the sod-3::gfp fusiondetect downregulation in neurons (Figure 3B). Neverthe-
less, the lifespans of these animals were reduced to to monitor DAF-16 activity. As a control, we introduced
our intestinal, neuronal, or muscle-specific daf-16 con-wild-type levels (Figure 3, legend). (We note that they
lived longer than daf-16; daf-2 double mutants, whose structs into daf-16(); daf-2() double mutants carrying
this reporter. We found that sod-3::gfp was upregulatedlifespans are about 20% shorter than normal [Lin et
al., 2001], consistent with a modest longevity role for only in intestine, neurons, or muscle, respectively (Figure
4A). Thus, DAF-16 regulates sod-3 expression cell au-neuronal daf-16.) Together these experiments con-
firmed that the neurons of these animals were refractory tonomously. Next we asked whether increased DAF-16
activity in one tissue could lead to the upregulation ofto RNAi, and indicated that inhibiting either daf-16 or
daf-2 activity can produce large changes in lifespan with sod-3 in other cells if the other cells were daf-16();
daf-2(). We found that overexpressing daf-16 in theno apparent change in neuronal daf-16 activity.
intestines of daf-16(); daf-2() animals increased sod-
3::gfp expression not only in the intestine, but also inDAF-16 Activity in Signaling Cells Can Increase
DAF-16 Activity in Responding Cells other tissues, including the epidermis (Figures 4B and
4F), head muscles (Figures 4C and 4G), and body mus-The expression of several insulin-like peptides is regu-
lated by DAF-2 and DAF-16 (Murphy et al., 2003), sug- cles (Figure 4F), though not neurons (Figure 4C). Neu-
ronal daf-16 increased sod-3::gfp expression not onlygesting that insulin-like peptides might function as
Tissue Specificity of DAF-16
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Table 3. Adult Lifespan of daf-16 Genetic Mosaics
Mean p value
lifespan No. died/ p value against
SEM total no. against specified
daf-16() lineage (days) animals# % control‡ control group
Exp. 1
all[daf-16(); daf-2() control] 17.0  0.4 96/146
AB 30.7  2.1 27/55 80.9% 0.0001 0.023$
P1 20.2  1.0 28/47 19% 0.0001 0.0001¶
E(MS) 25.9  0.8 89/135 52.6% 0.0001 0.0001$
none[daf-2() control] 36.2  1.2 116/169 113.3% 0.0001
Exp.2
all[daf-16(); daf-2() control] 16.6  0.3 135/352
AB 23.4  2.2 19/65 41% 0.0001 0.015$
P1 19.4  1.7 17/42 15.1% 0.003 0.02¶
E(MS) 24.8  1.2 78/185 49.4% 0.0001 0.005$
none[daf-2() control] 29.71.1 107/237 78.9% 0.0001
The statistical analyses performed here are as described in the Table 1 legend and in Experimental Procedures. For genotypes of strains see
Figure 2B and Experimental Procedures.
# Some animals were censored (see Experimental Procedures).
‡ % increase mean lifespan compared to daf-16(); daf-2() control.
The first set of p values represents the probability that the estimated survival function is equal to that of daf-16(); daf-2() controls. The
second set of p values is against a group specified by a superscripted symbol: $, daf-2() controls; ‡, E(MS) mosaics.
in neurons (Figure 4C), but also to a small but significant responding cells would require DAF-16 activity in those
cells. To test this, we examined daf-16(); daf-2(); sod-extent in the epidermis (Figure 4F), body muscle (Figure
4F), and head muscles (Figures 4C and 4G). In contrast, 3::gfp animals that overexpressed daf-16 in the intes-
tine. As expected, we saw no sod-3::gfp induction inmuscle daf-16 did not increase sod-3::gfp expression
in the epidermis (Figure 4F) or neurons (data not shown). nonintestinal tissues (Figures 4D–4G). Together these
findings indicated that DAF-16 acts in the intestine, andBecause sod-3 is thought to be a direct target of DAF-
16, we predicted that this increase in sod-3 expression in to a lesser extent in neurons, to control the production
Figure 3. daf-16 and daf-2 RNAi Affect Lifespan without Affecting Neuronal DAF-16 Activity
Wild-type (A) or daf-2(e1370) (B) animals carrying an integrated sod-3::gfp transgene (muIs84) were grown on bacteria expressing daf-2 or
daf-16 dsRNA, respectively. In both cases, they were compared to animals grown on control bacteria transformed with the vector alone. RNAi
treatment had no detectable effect on sod-3::GFP expression in neurons (n; arrows point at groups of neurons in the head), although it
dramatically affected the animals’ lifespans (animals carrying muIs84 on vector, mean lifespan m  20.1 days; muIs84 with daf-2 RNAi m 
43.2 days; daf-2; muIs84 on vector m  38.2 days; daf-2; muIs84 with daf-16 RNAi m  22.1 days). In (A), images of 2-day-old adults were
taken at 100	 magnification and 187 ms exposure time (left) or 1000	 magnification and 27 ms exposure time (right). Note increase in overall
fluorescence, arising from increased GFP expression in surrounding epidermal and other tissues, but no change in neuronal (n) GFP in daf-
2(RNAi) animals. In (B), images of L4 larvae were taken at 200	 magnification and 22 ms exposure time (left) or 1000	 magnification and
7 ms exposure time (right). Note decrease in overall fluorescence, but no change in neuronal (n) GFP in daf-16(RNAi) animals. We observed
similar results in animals up to 15 days old.
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Figure 4. DAF-16 Regulates sod-3 Expression both Autonomously and Non-autonomously
(A–E) The genotype of the strain is shown on top of each panel, the injected transgene on the side of the panel. (For specific strain information
see Experimental Procedures.)
(A and D) SOD-3::GFP and DAF-16::GFP were distinguished as described in Experimental Procedures. (A) In daf-16(mu86); daf-2(e1370);
muIs84 animals, DAF-16 regulates sod-3 expression cell autonomously (muIs84, sod-3::gfp transgene). From top to bottom: When driven by
its own promoter, DAF-16 upregulates sod-3::gfp in most tissues (mean lifespan was 31.3 days). Neuronal DAF-16 upregulates sod-3::gfp
only in neurons (hn, head neurons; tn, tail neurons; vcn, ventral cord neurons) (mean lifespan was 17.5 days). Muscle DAF-16 upregulates
sod-3::gfp only in muscle (arrowheads point to muscles in the body, m) (mean lifespan was 15.5 days). Intestinal DAF-16 upregulates sod-
3::gfp only in the intestine (arrowheads point to intestine, i) (mean lifespan was 24.4 days). Images of L4 larvae were taken at 200	magnification,
18 ms exposure time.
(B) When overexpressed in the intestine of wild-type worms carrying muIs84, DAF-16 can induce sod-3::gfp in the epidermis (e, arrows point
at epidermal nuclei). Images of 3-day-old adults were taken at 1000	 magnification, Nomarski micrograph (top), fluorescent microscopy
(bottom, 80 ms exposure time).
(C) Overexpression of DAF-16 in neurons (top) or the intestine (middle) of muIs84 animals can upregulate sod-3::gfp in the head muscles (hm;
Tissue Specificity of DAF-16
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of an intercellular signal that regulates DAF-16 activity P1  E[MS]-mosaics) lived 37% longer than normal.
However, these animals were not stress resistant (p in responding cells.
0.58 compared to daf-16(); daf-2(), Supplemental
Figures S5B and S5D). Similarly, in daf-16(); mes-1()Intestinal daf-16 Rescues the Longevity of daf-
sterile animals, intestinal daf-16 could completely res-16() Germline-Deficient Animals
cue lifespan (Figure 4C), whereas thermotolerance wasAt 20C, about 50% of mes-1(bn7) mutants lack the
only partially rescued (increased by 10%, p  0.009germline. These sterile animals live up to 50% longer
compared to daf-16(); mes-1() sterile controls, Sup-than their fertile siblings and their longevity is daf-16
plemental Figures S5C and S5D). Likewise, daf-16();dependent (Apfeld, 1999; Arantes-Oliveira et al., 2002).
mes-1() animals were very short-lived but exhibitedWe found that expressing daf-16 in the neurons or mus-
much higher thermotolerance than the wild-type animalscles of daf-16(); mes-1(bn7) double mutants had little
(Supplemental Figure S5D). Together these findingsor no effect on lifespan (Figures 5A and 5B; Table 1).
suggest that thermotolerance is not an absolute require-However, intestinal daf-16::gfp expression at levels
ment for longevity, and that mechanisms that do notcomparable to the control completely restored their lon-
confer thermotolerance play an important role in lifespangevity (Figure 5C; Table 1), as did daf-16::gfp expression
regulation. This is consistent with the finding that manyfrom the daf-16 promoter (Figure 5D; Table 1). Thus daf-
genes that have not been implicated in stress resistance16 activity in the intestine is sufficient to account for the
contribute to the longevity of daf-2 mutants (Lee et al.,longevity of germline-deficient animals.
2003; McElwee et al., 2003; Murphy et al., 2003).
Uncoupling Longevity and Stress Resistance
DiscussionDAF-2-pathway mutants and germline-deficient animals
are stress resistant (Arantes-Oliveira et al., 2002; Gems
Although their genotypes are identical, different individ-et al., 1998; Larsen, 1993; Lithgow et al., 1994, 1995;
uals within a population of C. elegans age at differentVanfleteren, 1993), and DAF-16 upregulates many
rates (Garigan et al., 2002; Herndon et al., 2002). How-stress-response genes (McElwee et al., 2003; Murphy
ever, with the exception of the nervous system, whichet al., 2003; Yu and Larsen, 2001) that contribute to daf-2
does not show signs of age (Herndon et al. 2002), withinlongevity (Hsu et al., 2003; Murphy et al., 2003). It was
a single animal, the rates of decline of different tissuescurious that lifespan could be extended without the in-
appear to be similar to one another (Garigan et al., 2002).creased expression of the stress-response gene sod-3
Thus, epigenetic mechanisms must play an importantin every tissue (see Figure 4A). Stress resistance is
role in coordinating the aging of the tissues. Our findingsthought to result from increased damage protection in
suggest that an elaborate signaling network may allowall cells of the animal. Therefore, we reasoned that if
the animal to achieve this coordination.sod-3 were representative of all stress response genes
(many of which, like sod-3 [Furuyama et al., 2000], have
daf-16 binding sites in their promoters [Murphy et al., Tissue-Specificity of DAF-16
In daf-2 mutants, DAF-16 is expressed in many tissues.2003]), then long-lived mosaics might not be stress re-
sistant. However, we found that intestinal daf-16 could By expressing daf-16 in specific tissues and carrying out
genetic mosaic analysis, we found that daf-16 activity inincrease the thermotolerance of daf-16(); daf-2()
double mutants by 59% (Supplemental Figure S5A). any of three tissues: neurons, intestine, or an unidenti-
fied nonintestinal P1-derived tissue, was able to extendThus, either daf-16 can regulate stress resistance cell
non-autonomously (in which case at least some stress- lifespan. If DAF-16 acted in a purely cell-autonomous
fashion to influence only the lifespan of the cells in whichresponse genes do not require direct DAF-16 binding
for their expression), or the intestine is particularly sus- it was expressed, then its activity in any one of several
tissues or lineages (either AB or P1) should not haveceptible to stress.
We tested the heat resistance of a number of strains enabled the animal to live longer than the longest-lived
daf-16(); daf-2() control animals. Therefore, we con-that had various degrees of lifespan extension, and
found that there was not a consistent correlation be- clude that DAF-16 influences lifespan cell non-autono-
mously by regulating a signaling pathway that acts ontween thermotolerance and lifespan. Altogether, mosa-
ics that had lost daf-16 within the P1 lineage (that is, many tissues of the animal.
GFP-intensities are denoted by and respectively) (compare to controls carrying the coinjection marker rol-6 (pRF4) alone [bottom,]).
Note that neuronal sod-3::gfp is not upregulated in animals in which DAF-16 is overexpressed in the intestine (*) or the muscles (data not
shown), and is only upregulated when DAF-16 is overexpressed in the neurons (**). Images of 3-day-old adults were taken at 630	magnification,
80 ms exposure time.
(D and E) The cell non-autonomous upregulation of sod-3::gfp requires DAF-16 in responding cells. In a daf-16(mu86); muIs84 background,
intestinal DAF-16 causes sod-3::gfp upregulation only in the intestine (D). It is not upregulated in the head muscles (E) (compare to [C]). Image
of a 3-day-old adult was taken at 100	 magnification (D), and 630	 magnification (E), 80 ms exposure time.
(F) Percentage of animals overexpressing daf-16 in specific tissues (indicated on the bottom of the graph) in which sod-3::gfp was upregulated
non-autonomously in the epidermis (e) or the body muscle (bm). We did not include body muscle induction for muIs84Pmyo-3, since in
these animals DAF-16 is present in the muscles (*). Animals were scored under 1000	 magnification in three or more experiments.
(G) Percentage of animals overexpressing daf-16 in specific tissues (see bottom of the graph) with a certain intensity ( to ) of sod-
3::gfp induction in the head muscles (hm) (examples of ,  and  can be seen in [C]). Animals were scored under 630	 magnification
in two or more experiments. In (F) and (G), the total number of animals scored for each genotype is indicated above each set of bars.
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Figure 5. Intestinal daf-16 Expression Rescues the Longevity of daf-16() Germline-Defective Animals
(A–D) Effects of tissue-specific daf-16 expression on the lifespan of daf-16(mu86); mes-1(bn7) sterile animals. Only sterile animals were
analyzed in these experiments. The coinjection marker, Podr-1::rfp, alone had no effect on the lifespan of daf-16(mu86); mes-1(bn7) animals
(p 0.11). Neuronal DAF-16 has a small effect (A) and muscle DAF-16 has no effect (B) on the lifespan of daf-16(mu86); mes-1(bn7) sterile
animals. (C) Intestinal DAF-16 can rescue the lifespan of daf-16(mu86); mes-1(bn7) sterile animals to mes-1(bn7) sterile levels. (D) daf-16
driven by its own promoter can rescue the lifespan of the daf-16(mu86); mes-1(bn7) mutants to mes-1(bn7) levels. daf-16; mes-1-S represents
non-RFP-expressing sterile siblings selected under the fluorescent dissecting scope in parallel with transgenic animals. They behave similarly
to daf-16(mu86); mes-1(bn7) animals not treated with fluorescence (p 0.1).
Genetic mosaics expressing daf-16 only in the AB DAF-16 May Regulate Two Types
of Downstream Signalslineage, which produces all but a few neurons, lived only
about 20% longer than normal. Likewise, neuronal daf- DAF-2 is the only insulin/IGF-1 receptor in C. elegans,
and the longevity of daf-2 mutants is dependent on DAF-16 increased lifespan only by 5%–20%. Though unex-
pected, this is consistent with our previous observation 16 (Gems et al., 1998; Kenyon et al., 1993; Larsen et al.,
1995; Lin et al., 2001). Thus, the fact that tissue-specific(confirmed here as well, Supplemetnal Figure S2 avail-
able online at http://www.cell.com/cgi/content/full/115/ DAF-16 activity can influence daf-16(); daf-2() re-
sponding cells suggests that DAF-16 regulates a non-4/489/DC1) that when driven by the daf-16 promoter,
daf-16::gfp is expressed at relatively low levels in the insulin-like downstream signal or hormone. In addition,
we found that in a wild-type background, overexpres-nervous system (Lin et al., 2001). Interestingly, daf-16
expression in the nervous system increases markedly sion of DAF-16 in one tissue could upregulate DAF-16
activity in other cells. DAF-16 could potentially exert thisduring dauer formation (Lin et al., 2001), and we found
that neuronal daf-16 expression was sufficient to induce effect by regulating an insulin-like signal. The expression
of several insulin-like genes, including the putative DAF-2dauer formation (Table 2). Thus, it is possible that DAF-
16’s activities in lifespan regulation and dauer formation agonist ins-7, is regulated by DAF-2 and DAF-16 (Mur-
phy et al., 2003). Possibly DAF-16 activity in signalingare separated spatially as well as temporally (Dillin et
al., 2002). Finally, we note that daf-2 may function in a cells stimulates DAF-16 activity in responding cells by
downregulating ins-7 or another DAF-2 agonist, or bycomplex manner in the nervous system to regulate
aging. In our previous daf-2 mosaic analysis, we identi- upregulating a DAF-2 antagonist. Interestingly, we found
that some tissues (for example, the intestine) were betterfied one very long-lived mosaic (ABalpppap) that lacked
daf-2 only in a small set of neurons (Apfeld and Kenyon, able than others (neurons and muscles) to activate DAF-
16 in responding cells. Conversely, some tissues (for1998). However, ABa-mosaics, which lacked daf-2 in
these and many other neurons as well, were not long- example, the epidermis) were much more responsive
than others (neurons) to this type of signaling. It will belived.
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interesting to learn whether this pattern correlates with Intestinal daf-16 Plays an Important Role
in Lifespan Regulation by the Germlinethe pattern of any insulin gene expression, or with fac-
tors that influence insulin-sensitivity in responding cells. In long-lived germline-deficient animals, DAF-16 nuclear
accumulation takes place primarily in the intestine (Lin
et al., 2001; this study). Consistent with this, intestinal
Possible Solutions for Apparent Paradoxes daf-16 expression could completely restore the longev-
Our previous daf-2 genetic mosaic analysis suggested ity of daf-16() germline-deficient animals. This sug-
that daf-2, and thus presumably daf-16, acts primarily gests that DAF-16 may function primarily in the intestine
in the AB lineage (Apfeld and Kenyon, 1998), whereas to increase the lifespan of germline-deficient animals.
the mosaic analysis in this study suggests that daf-16 Interestingly, animals that lack a germline live approxi-
acts primarily in the P1 lineage to influence lifespan. How mately as long as daf-16(); daf-2() animals express-
could this be? In the daf-16 site-of-action experiments ing daf-16 only in the intestine. Thus, the germline path-
described here, the responding cells were daf-16(), way may function through an intestinal branch of the
whereas in the daf-2() mosaic analysis, the responding insulin/IGF-1 system.
cells were wild-type. Therefore, in the daf-2 (but not It was interesting to find that the intestine plays such
the daf-16) mosaic analysis, lifespan could have been an important role in the regulation of longevity. It is
influenced by downstream signals that act through DAF- possible that some of the stress-response and anti-
16. Perhaps one or more AB-derived tissues regulate microbial genes regulated by DAF-16 are particularly
such a signal. Our experiments suggest that, while neu- important in the intestine, which is relatively exposed
rons contribute to this type of signaling, the contribution to environmental toxins and pathogens. Previously, we
from the intestine, a P1-derived tissue, is even greater. showed that wild-type worms fed live but nonproliferat-
Thus nonneuronal AB-derived cells may also produce ing bacteria live about 30% to 40% longer than normal
such a signal. A number of insulin-like peptides are pro- (Garigan et al., 2002). Genetic mosaics lacking DAF-16
duced by nonneural tissues within the AB lineage, con- specifically in the intestine (MS) lived approximately
sistent with the model that this pathway involves insu- 30% shorter than control daf-16(); daf-2() animals.
lin signaling. Perhaps the loss of cell-autonomous DAF-16 activity in
How can we reconcile our findings with those of Wol- the intestine contributes to this lifespan shortening. The
kow et al. (2003), who proposed, based on the shortened intestine, which is the entire endoderm of the animal, is
lifespans of animals in which daf-2 was expressed under also the primary site of fat storage in C. elegans, and
the control of neural promoters in a daf-2(e1370) back- thus behaves as the animal’s adipose tissue (Ashrafi et
ground, that DAF-2 functions primarily in the nervous al., 2003; Kimura et al., 1997). FIRKO mice, which lack
system to regulate longevity? Our tissue-specific ex- the insulin receptor in adipose tissue, are also long-lived
pression, mosaic analysis, and RNAi experiments each (Blu¨her et al., 2003). This suggests that this tissue may
imply that inhibition of DAF-16 activity in neurons alone have acquired a role in the regulation of longevity early
would not be sufficient to prevent daf-2 mutants from in evolution. If so, then the mechanisms by which it
living far longer than normal. We considered the possi- exerts its effects on lifespan may also be conserved.
bility that the daf-2() neurons in the animals of Wolkow Finally, it is possible that the intestine functions as the
et al. produced a signal that could act on daf-2() intes- pancreas of C. elegans to produce insulin in response
tinal and other cells to downregulate daf-16 activity. to food. The pancreas, too, is an endodermal organ, and
However, using daf-2 RNAi, we too created animals that its ability to produce insulin is regulated by the insulin
appeared to be daf-2() in neurons but daf-2() in other receptor (Kulkarni et al., 1999). Likewise, we found that
cells, but, as assayed using the sod-3::gfp reporter, daf- intestinally-expressed DAF-16 could modulate DAF-16
16 activity in the intestine and other nonneuronal cells activity in responding cells, as would be expected if the
was high in these animals, not low. Further experiments DAF-2 pathway acts in intestinal cells to regulate the
may resolve this apparent paradox. release of insulin-like peptides.
ConclusionControl of Downstream Gene Expression
We found that expression of daf-16 in any of several
tissues or lineages was sufficient to extend lifespan, Together our findings suggest that an intricate signaling
network regulates the lifespan of C. elegans. In responseindicating that daf-16 regulates a downstream signal (or
signals) that acts non-autonomously to influence tissue to their own levels of DAF-2 pathway activity, certain
tissues engage in intercellular signaling that influencesaging. Yet many genes that seem likely to affect longev-
ity directly, including a wide variety of stress-response, DAF-16 activity in responding cells. Because logically
this is a feed-forward signaling system, it could haveantimicrobial, and metabolic genes, have binding sites
for DAF-16 in their promoters. Moreover, our findings the effect of equalizing the levels of DAF-2 pathway
activity among different cell types. In addition, DAF-16show that at least one of these genes, sod-3, requires
the cell-autonomous activity of DAF-16 for its increased activity causes some tissues to produce intercellular
signals that act on target tissues in a DAF-16-indepen-expression in DAF-2 mutants. It will be interesting to
learn whether this is the case for other genes as well. dent fashion. By regulating DAF-16 activity in re-
sponding cells, the first signaling pathway may also in-If so, then the cell autonomous function of DAF-16 would
be expected to contribute to the longevity of daf-2 mu- fluence the second pathway. In addition, both types of
signals have the potential to act in an autocrine fashiontants. Perhaps this explains why none of our daf-16
mosaics lived as long as control daf-16() animals. on the signaling cells themselves.
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Mosaic AnalysisThe insulin/IGF-1 system affects many physiological
We used a daf-16(mu86); daf-2(e1370) ncl-1(e1865); muEx258processes, including dauer formation, reproduction,
(CF1803) strain to generate daf-16 genetic mosaics in two indepen-stress resistance, and metabolism as well as aging, and
dent experiments (daf-16(mu86) is a null allele [Lin et al., 1997]);
all of these processes may require close coordination muEx258 is an extrachromosomal array containing a genomic copy
between different tissues. This network of signaling may of daf-16, as well as lineage-specific markers; for strain construction
information see Supplemental Experimental Procedures). In experi-allow the animal to achieve this coordination. In addition,
ment #1, daf-16(mu86); daf-2(e1370) ncl-1(e1865); muEx258 animalstissue-specific signaling may allow different tissues to
were grown continuously at 20C and approximately 200,000 prog-make unique, or at least finely-tuned, contributions to
eny of these animals were screened under the fluorescent dissectingthe system as a whole; for example, by influencing ex-
scope for mosaic animals in which the AB-specific fluorescent
pression of downstream genes. Finally, the use of inter- marker, Posm-6::gfp (which is expressed in all ciliated neurons), or
related signaling pathways that incorporate positive the E-specific fluorescent marker, Pges-1::gfp (which is expressed
in the intestine generated by the P1 lineage) was absent. In somefeedback regulation may allow the system to adjust rap-
animals, the loss of the array in the AB lineage was confirmed byidly and effectively to internal or environmental perturba-
looking at the cell-autonomous Ncl phenotype (enlarged nucleolus)tions.
using Nomarski optics (Hedgecock and Herman, 1995). Since the
germline is generated by P4, we distinguished P1- from E(MS)-Experimental Procedures
mosaics by determining whether some of their progeny carried the
array. E(MS)-mosaics probably contained a mixture of E- andFor information on strain construction and thermotolerance assays
EMS-mosaics: we could not distinguish between the two becausesee Supplemental Experimental Procedures available online at
we did not have an MS-specific fluorescent marker on the array.http://www.cell.com/cgi/content/full/115/4/489/DC1.
Mosaics were selected as L4 larvae or, for some AB-mosaics, as
dauers (15% of all AB-mosaics). Lifespan analysis was then initi-
Molecular Biology ated for L4 mosaics. Dauers were allowed to resume development
To generate daf-16 tissue-specific promoter fusions, HindIII and at 15C prior to the lifespan analysis.
SnaB1 sites were introduced immediately 5
 to the first ATG by PCR In experiment #2, daf-16(mu86); daf-2(e1370) ncl-1(e1865); muEx258
amplification of the daf-16 cDNA construct (yk13f11, identified by animals were moved from 15C to 25.5C as gravid P0’s, and approxi-Y. Kohara) using an inverse PCR strategy (HindIII is more proximal mately 400,000 progeny were screened as described above. Mosaic
to the ATG). A HindIII GFP fragment from the L2911 plasmid (gift animals were selected as dauers or L4 larvae, which were moved
from A. Fire) was inserted into the HindIII site to generate an in- to 20C for lifespan analysis. Dauers were allowed to resume devel-
frame fusion of GFP immediately upstream of the N terminus of opment at 15C and, upon reaching the L4 stage, were moved to
DAF-16a (pNL205). The SnaB1 site was used to insert the following 20C for lifespan analysis. daf-2() controls (array present in all
tissue-specific promoter fragments: Pdaf-16, which contains 6 kb cells), which were selected as dauers at 25.5C, underwent the same
of the daf-16 5
 regulatory sequence amplified by PCR from cosmid treatment. In both experiments, the daf-2() and the daf-16();
R13H8 (pNL209); pan-neuronal Punc-119, which contains 2.2 kb daf-2() (array lost in all cells) controls were selected under the
upstream sequence of the unc-119 gene (Maduro and Pilgrim, 1995), fluorescent dissecting scope in parallel with the mosaic animals and
subcloned into pNL205 using blunt-ended XbaI/BamHI flanking were exposed to UV radiation for approximately the same time.
sites, (pNL206); muscle Pmyo-3, which has 2.5 kb upstream regula-
tory sequence of this gene PCR-amplified from pPD93.97 (gift from
A. Fire) (pNL212); intestinal Pges-1, which has 3.3 kb upstream Lifespan Analysis
sequence (Aamodt et al., 1991) PCR-amplified from pJM16 Lifespan assays were performed at 20C and were initiated at the
(pNL213); epidermal Plin-26, which has 4.6 kb upstream sequence L4 larvae stage. Animals were transferred away from their progeny
(den Boer et al., 1998; Labouesse et al., 1994) PCR-amplified from to new plates every other day until the end of the reproductive
pML006 (pNL208); epidermal (also expressed in neurons) Punc-115, period (except when animals were sterile, in which case they were
which has 1.5 kb upstream sequence PCR-amplified as previously kept on the same plates). Strains carrying tissue-specific promoter
described (Lundquist et al., 1998) (pNL216). PCR-amplified daf-16 fusions in daf-16(mu86); daf-2(e1370) background, as well as their
coding sequence and all PCR-amplified promoter fragments, as controls, were grown at 15C prior to lifespan analyses. Strains
well as the 5
 and 3
 junctions with the GFP, were subsequently carrying tissue-specific promoter fusions in daf-16(mu86); mes-
sequenced. To generate transcriptional Pges-1::gfp fusion 1(bn7) background and their respective controls were continuously
(pNL215), the HindIII/AgeI Pmyo-3 fragment in pPD93.97 was re- grown at 20C. To initiate lifespan assays in those animals, we picked
placed by the SnaBI Pges-1 fragment from pNL213. To generate synchronized L4 larvae and separated sterile animals from their
transcriptional Psod-3::gfp fusion (pJR2), 1.1 kb fragment, which fertile siblings one day later (based on the absence or presence of
includes the upstream sequence and the first exon of the sod-3, germ cells detectable under the dissecting scope; sterility was also
was amplified from the C.elegans genomic DNA and cloned into confirmed by the lack of progeny in those animals). In all transgenic
SphI/XbaI sites of pPD95.69 (gift from A. Fire). lines carrying the Podr-1::rfp coinjection marker, the transgenic ani-
mals and their nontransgenic siblings were separated under the
fluorescent dissecting scope and were exposed to UV radiation forTransgenic Animals
Standard techniques were used to perform germline transformation approximately the same time. In daf-16(mu86); daf-2(e1370); muIs84
carrying muEx211 or muEx227, animals in which Pges-1::gfp::daf-(Mello and Fire, 1995). Tissue-specific promoter constructs were
injected into the daf-16(mu86); daf-2(e1370), daf-2(e1370), or daf- 16 was expressed more uniformly were selected for lifespan analysis
based on the more uniform induction of sod-3::gfp in the intestine16(mu86); mes-1(bn7) animals to generate independent transgenic
lines (indicated by a muEx number; see Table 1 for concentrations (detectable under fluorescent dissecting scope). When coinjected
with Podr-1::rfp, Pges-1::gfp::daf-16 was expressed at higher levelsof injected transgenes). Plin-26::gfp::daf-16 and Punc-115::gfp::daf-
16 were injected at concentrations ranging from 1 ng/l to 100 ng/ and was visible under the fluorescent dissecting scope, which al-
lowed us to select animals with more uniform intestinal GFP expres-l into daf-16(mu86); daf-2(e1370) with rol-6 (pRF4) at 100 ng/l
and Podr-1::rfp at 100 ng/l respectively as coinjection markers. sion directly. We used Statview 4.5 (SAS) software to carry out
statistical analysis and to determine mean lifespans. Animals thatTissue-specific GFP expression was confirmed using Nomarski and
fluorescent microscopy (see Supplemental Figures S1–S3). For Plin- crawled off the plate, “exploded” (i.e., had a gonad extruding
through their vulva), or “bagged” (i.e., died from internal hatching)26::gfp::daf-16, GFP expression was detectable in dead embryos
only, as we failed to obtain any viable transgenic lines. For Punc- were censored at the time of the event and were incorporated into
the data set as described (Lawless, 1982). Expressing daf-16 in the115::gfp::daf-16, epidermal GFP expression was observed in ar-
rested L1 larvae and arrested embryos but only neuronal GFP ex- daf-16(mu86); daf-2(e1370) background from Pdaf-16, Punc-119,
and Pges-1 promoters resulted in a higher proportion of “bagged”pression was observed in transgenic animals that grew to adulthood.
Tissue Specificity of DAF-16
501
animals (34%–66%, up to 18% and up to 24%, respectively) com- Blu¨her, M., Kahn, B.B., and Kahn, C.R. (2003). Extended longevity
in mice lacking the insulin receptor in adipose tissue. Sciencepared to daf-2(e1370), daf-16(mu86); daf-2(e1370) and N2 controls
(7%,4%, and 6%, respectively). 299, 572–574.
den Boer, B.G.W., Sookhareea, S., Dufourcq, P., and Labouesse,
sod-3::gfp Induction Assays M. (1998). A tissue-specific knock-out strategy reveals that lin-26
In daf-16(mu86); daf-2(e1370); muIs84 animals carrying the tissue- is required for the formation of the somatic gonad epithelium in
specific daf-16 fusions (Figure 4A and Supplemental Figure S3), we Caenorhabditis elegans. Development 125, 3213–3224.
distinguished between the GFP fluorescence obtained from the sod-3:: Dillin, A., Crawford, D.K., and Kenyon, C. (2002). Timing require-
gfp and daf-16::gfp transgenes based on the following criteria: tis- ments for insulin/IGF-1 signaling in C. elegans. Science 298,
sue-specific daf-16 induced much higher sod-3::gfp fluorescence 830–834.
(visible under a fluorescent dissecting microscope) than was ob-
Fraser, A.G., Kamath, R.S., Zipperlen, P., Martinez-Campos, M.,tained from the daf-16::gfp transgene (visible only under higher mag-
Sohrmann, M., and Ahringer, J. (2000). Functional genomic analysisnifications). In addition, in a daf-2() background, sod-3::gfp is
of C.elegans chromosome I by systematic RNA interference. Naturefound both in the cytoplasm and in the nuclei, whereas daf-16::gfp
408, 325–330.is predominantly nuclear. We used sod-3::gfp expression as a re-
Furuyama, T., Nakazawa, T., Nakano, I., and Mori, N. (2000). Identifi-porter for daf-16 transcriptional activity.
cation of the differential distribution patterns of mRNAs and consen-In Figures 4B–4G, well-fed animals were grown at 15C and trans-
sus binding sequences for mouse DAF-16 homologues. Biochem.ferred to 20C as L4 larvae (20–30 per plate). As 3-day-old adults,
J. 349, 629–634.these animals were mounted on 2% agarose slides (6–8 per slide),
and the induction of the sod-3::gfp in different tissues was assayed Garigan, D., Hsu, A.-L., Fraser, A.G., Kamath, R.S., Ahringer, J., and
using fluorescent and Nomarski microscopy. Kenyon, C. (2002). Genetic analysis of tissue aging on C. elegans:
A role for heat-shock factor and bacterial proliferation. Genetics
161, 1101–1112.Dauer Assays
To determine the relative frequencies of dauer/larval arrest and L4 Gems, D., Sutton, A.J., Sundermeyer, M.L., Albert, P.S., King, K.V.,
larvae in daf-16(mu86); daf-2(e1370) animals carrying tissue-spe- Edgley, M.L., Larsen, P.L., and Riddle, D.L. (1998). Two pleiotropic
cific daf-16, we placed eggs (50–80 per plate) at 25.5C or 27C classes of daf-2 mutation affect larval arrest, adult behavior, repro-
and scored dauer formation after 48 and 72 hr. We counted duction and longevity in Caenorhabditis elegans. Genetics 150,
transgenic (Rol) animals that had reached the L4 stage after 48 hr. 129–155.
To distinguish between different stages of larval and dauer arrest Golden, J.W., and Riddle, D.L. (1982). A pheromone influences larval
among the transgenic animals, after 72 hr we mounted 10–15 ani- development in the nematode Caenorhabditis elegans. Science
mals per pad (2% agarose containing 1.5-3 mM NaN3 as an anesthe- 218, 578–580.
tic) and examined them under Nomarski microscopy. The presence
Golden, J.W., and Riddle, D.L. (1984). The Caenorhabditis elegansof GFP was confirmed using fluorescent microscopy. Embryonic
dauer larva: developmental effects of pheromone, food, and temper-lethality was estimated based on the number of unhatched eggs on
ature. Dev. Biol. 102, 368–378.the plates (there was no embryonic lethality in daf-16(mu86); daf-
Gottlieb, S., and Ruvkun, G. (1994). daf-2, daf-16 and daf-23: geneti-2(e1370) animals). For daf-2(e1370) controls, relative frequencies of
cally interacting genes controlling Dauer formation in Caenorhab-larval and dauer arrest were first scored at 48 hr and then confirmed
ditis elegans. Genetics 137, 107–120.at 72 hr.
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